Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Nutex Health (NUTX) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Nutex Health (NUTX) over the last 17 years, with Q3 2025 value amounting to 48.68%.

  • Nutex Health's EBIT Margin rose 364200.0% to 48.68% in Q3 2025 from the same period last year, while for Sep 2025 it was 36.58%, marking a year-over-year increase of 399100.0%. This contributed to the annual value of 27.23% for FY2024, which is 400600.0% up from last year.
  • Latest data reveals that Nutex Health reported EBIT Margin of 48.68% as of Q3 2025, which was up 364200.0% from 13.8% recorded in Q2 2025.
  • Over the past 5 years, Nutex Health's EBIT Margin peaked at 63.12% during Q3 2021, and registered a low of 1509.7% during Q3 2022.
  • In the last 5 years, Nutex Health's EBIT Margin had a median value of 6.96% in 2024 and averaged 75.86%.
  • Per our database at Business Quant, Nutex Health's EBIT Margin crashed by -15728200bps in 2022 and then skyrocketed by 15083900bps in 2023.
  • Over the past 5 years, Nutex Health's EBIT Margin (Quarter) stood at 24.51% in 2021, then plummeted by -144bps to 10.76% in 2022, then plummeted by -249bps to 37.53% in 2023, then skyrocketed by 218bps to 44.33% in 2024, then rose by 10bps to 48.68% in 2025.
  • Its EBIT Margin stands at 48.68% for Q3 2025, versus 13.8% for Q2 2025 and 38.09% for Q1 2025.